Skip to main content
Premium Trial:

Request an Annual Quote

Inpharmatica, Chiron in Informatics-Based Research Alliance

NEW YORK, Feb. 24 - Inpharmatica, a London-based informatics company, said today that it has begun a research collaboration with Chiron to prioritize protein targets using its PharmaCarta chemogenomics informatics platform.


Inpharmatica said it will apply the technology platform - which is used to functionally annotate full-length proteins -- to assess the druggability of proteins in genomic datasets from Chiron's oncology research program.


The agreement is Inpharmatica's second relationship involving the application of its technology outside its own internal discovery programs and the first involving druggability assessment. In January, the company expanded an existing research collaboration with Serono.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.